- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 14, 2026 | 32.2M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 32.2M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 29.28M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$4.54M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$704.95K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $10.94M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $13.2M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $18.01M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $21.31M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $36.6M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $23.76M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $9.1M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $9.51M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $9.1M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $9.51M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $14.13M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $27.27M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $27.11M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $30.82M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.16 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.21 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.16 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.21 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $1.05M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $1.36M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $3.62M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $5.16M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$5.26M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$6.2M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$4.67M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$6.52M |
| Short Term Investments | Q1 2026 · Dec 31, 2025 | $11.24M |